Finding an online GLP-1 clinic should not feel like diving into the latest gambling app, but it often does. Some programs look affordable until you learn they rely on lightly regulated compounded meds. Others offer real medical oversight but charge thousands before you even start.
For men who want something effective and straightforward, those trade-offs are hard to ignore.
That gap between safety and cost is the Quality-Price Gap. Hims claims to bridge it with fast access, clear pricing, and multiple medication options. Does it deliver?
This article is for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before starting any new treatment.
📋Our Score: 3/5
| Category | Rating |
|---|---|
| Results | ★★★☆☆ |
| Ease of use | ★★★★☆ |
| Medical expertise | ★★★☆☆ |
| Cost & transparency | ★★★★☆ |
| Customer support | ★★☆☆☆ |
We evaluate telehealth clinics based on the latest GLP-1 research, customer feedback, clinical transparency, and patient experience. See how we review GLP-1 therapies.
| Pros | Cons |
|---|---|
| ✅ Transparent pricing tiers | ❌ Limited provider interaction |
| ✅ No membership fees | ❌ Prepaid plans impose commitment burden |
| ✅ No labs required unless indicated by provider | ❌ Few educational or behavioral support resources |
| ✅ Designed for men and performance goals | ❌ Does not accept insurance |
| ✅ Multiple medication options | |
| ✅ Fast approval and shipping |
What Is Hims?

Hims is a virtual clinic built for men, offering prescription treatments for weight loss, sexual health, hair loss, and mental health without the hassle of in-person appointments or insurance approvals. The GLP-1 weight-loss program follows the same model: online intake, provider review, and medication shipped to your door.
Hims’ main selling point is how straightforward it makes the process: clear prices, quick sign-up, and the option to choose between compounded or branded meds. However, it’s important to note that compounded GLP-1s are not FDA approved.
Compounded meds may reflect disparities in ingredients and quality, but they are typically safe when sourced from FDA-regulated 503A facilities, which Hims partners with.[1]
The process is fully digital and designed for minimal friction. The flip side is that the medical supervision is minimal, so you’re trading hands-on care for speed and simplicity.
What About Hers?
Hers is the sister platform for women, operating under the same Hims & Hers Health umbrella. The structure, pricing, and medication options are nearly identical. The main difference is marketing: Hers emphasizes approachable, stigma-free care, while Hims leans into confidence and performance-driven messaging.
This review focuses on Hims specifically, but the core experience applies to both platforms.
How Does Hims Work?

Signing up for Hims happens completely online, from intake to approval. After you submit your medical info, a licensed provider reviews it remotely to decide whether you qualify for GLP-1 treatment. The program is designed for convenience and fast access, helping patients begin treatment quickly while minimizing in-person barriers.
Most users can complete onboarding within a few days, though timelines may vary depending on provider availability and state regulations. Here’s what to expect step by step:
Step 1: Membership & Intake
The process starts with a brief medical form where you enter your health history, weight, habits, and goals so the provider has the basics. The form takes about 10–15 minutes and serves as the foundation for your provider’s eligibility review.
Start the assessment on the Hims website.
Step 2: Provider Evaluation & Eligibility Review
A licensed Hims provider reviews your intake to determine whether GLP-1 medication is appropriate. Hims uses the standard FDA criteria for GLP-1s: a BMI of 30+, or 27+ if you have a related condition like diabetes or high blood pressure.[2]
In most states, this review happens asynchronously through secure messaging. Some states may require a brief video or phone visit before a prescription is issued.[3]
Step 3: Lab Testing (if needed)
Hims does not typically require lab testing to start treatment. However, if your provider flags potential health concerns such as thyroid issues, high blood sugar, or liver disease, you may be asked to complete labs before beginning medication. When required, these tests are paid out of pocket.[4]
Step 4: Treatment Plan & Shipping
Once approved, you’ll receive a personalized treatment plan that outlines medication type, dosage, and frequency. Depending on your plan, Hims may prescribe compounded GLP-1 injections or oral weight-loss medication kits. Prescriptions are filled and shipped directly to your door in discreet packaging, where available.
Step 5: Ongoing Care
After treatment begins, you can message your provider through the Hims platform to ask questions, report side effects, or request dose adjustments. Hims advertises “unlimited medical consultations,” offering flexibility for follow-up conversations, though it does not include structured coaching or scheduled check-ins.
Treatment Options at Hims

- Weekly GLP-1 or GIP/GLP-1 injections: compounded semaglutide; FDA-approved semaglutide formulations (Wegovy®*, Ozempic®); and tirzepatide-based options (Zepbound®, Mounjaro®).
- Daily GLP-1 injections: generic liraglutide
- Non-GLP-1 medication: naltrexone + bupropion; metformin; topiramate; vitamin B12
- Other support tools:
- Hims app for messaging provider
- Educational resources
- Meal-replacement shakes and bars
Note: Wegovy is still listed as an option on the Hims website, but Novo Nordisk recently announced it is ending its collaboration with Hims & Hers.[5] Access may vary depending on state and current supply.
Hims Pricing: Straightforward and Simple
Pricing for Hims’ weight-loss medications depends on the treatment type and payment plan. There’s no monthly membership fee, but all plans require a prepaid commitment.
You can use HSA or FSA funds to pay, but insurance isn’t an option with Hims.
Initial lab test: Not included; $75–$100 if required
Injectable GLP-1s:
- Compounded semaglutide*:
- $199/month with 12-month commitment
- Shorter term plans may be available, but you will likely pay more.
- Not available in Alabama, Arkansas, Louisiana, or Mississippi
- Liraglutide: $299/month with 12-month commitment
- Wegovy: $1,999/month
- Ozempic: $1,799/month
- Mounjaro: $1,899/month
- Zepbound: $1,899/month
Oral non-GLP-1 weight-loss medication: $69/month
Oral meds are available only as part of a 10-month prepaid plan:
- naltrexone + bupropion
- metformin
- topiramate
Pricing is easy to understand, with no hidden fees or surprise add-ons. Committing up front offers lower rates, which is appealing if you plan to stay long term. That said, the requirement to pay several months in advance may frustrate users who prefer flexibility. Its value depends on how confident you are in staying the course.
How Hims compares:
- Peak Wellness skips the FDA-approved branded route for cheaper compounded GLP-1s at one flat price; our Peak Wellness vs Hims comparison weighs the trade-off.
- Ro Body Program features a similar structure to Hims with compounded semaglutide, but pricing is higher and choices are narrower. Coaching and insurance support are included, however.
- Found charges a base membership plus medication costs, making it more customizable but often pricier overall.
- WeightWatchers includes insurance navigation and clinical support, which can lower costs for covered patients but raises fees for those paying out of pocket.
Hims stands out for offering an all-in-one model that’s predictable, convenient, and quick to start; it’s best suited for those who value simplicity over customization.
What’s Included in the Hims Plan?
- Initial consultation
- Medication
- Shipping
- Injection supplies (where applicable)
- App-based support (messaging, dosage guidance, and educational resources such as protein targets and sleep content)
What’s Missing?
- Routine labs ($75–$100 out of pocket, if requested)
- Dietitian coaching or structured lifestyle support
- Community access
True Value Score™: B-
| Category | Grade | Why it matters |
|---|---|---|
| Total investment analysis | B | With plans beginning at $199, Hims is among the cheapest ways to start GLP-1 treatment without using insurance, but all plans require prepaid commitments. The lack of month-to-month flexibility is the main cost drawback, as is the expensive lab work, should you need it. |
| Medical excellence standards | C+ | Care is licensed and legitimate, but oversight is minimal. Labs are rarely required, compounded meds are pushed over FDA-approved options, and provider interaction means texting through an app. The bare-bones model cuts costs but also cuts the level of medical expertise you’d get with hands-on programs. |
| Outcome-success tracking | B- | Hims offers app-based progress tracking, but everything is self-directed. There are no scheduled check-ins, no coaching, and no required provider follow-ups before refills. You can message a provider if something comes up, but ongoing accountability is not built into the program, which limits long-term support. |
Lab Testing: What Gets Measured and Why It Matters

Routine labs aren’t required to start with Hims. Your provider may order tests if your history or intake raises a concern (thyroid issues, high blood sugar, liver history). If labs are needed, expect to pay $75–$100 out of pocket.
- A1C (hemoglobin A1C): Reflects average blood sugar over the past 2–3 months. Helpful for spotting prediabetes or insulin resistance, which can influence dose strategy and side-effect risk.
- Fasting glucose: Shows how your body handles blood sugar in the moment. Higher values can signal early insulin resistance or diabetes and may affect your starting dose and monitoring plan.[6]
- Lipid panel (cholesterol): Looks at HDL, LDL, and triglycerides. A baseline helps you see how weight loss shifts your numbers and informs cardiovascular risk over time.[7]
- Liver enzymes (ALT, AST): Checks liver inflammation. GLP-1s aren’t typically liver-toxic and are being studied for improvement with fatty liver disease (MASLD/MASH).[8][9] A baseline is still smart if you have liver history or take liver-metabolized meds.
- Kidney function (creatinine, BUN, eGFR): Assesses renal workload. Dehydration from nausea or lower intake can stress kidneys.[10] Monitoring kidney function matters especially for older adults or those with preexisting kidney disease.
- TSH (thyroid-stimulating hormone): Screens thyroid status. Low thyroid function can drive weight gain and fatigue; knowing TSH helps tailor the plan.[11]
- Electrolytes: Checks sodium, potassium, and others. Useful for catching imbalances that can worsen with vomiting or diarrhea early in treatment.
- CBC (complete blood count): A quick health snapshot. Can flag anemia, infection, or inflammation that might affect tolerance or dosing.
How often do you need labs?
With Hims, labs usually aren’t mandatory. Most patients complete testing only at baseline if a provider sees a reason. That keeps the process fast and convenient, but it also means fewer built-in safety check-ins than you’d get with a high-touch clinic. If you want tight monitoring, that’s a trade-off; if you prefer speed and lower hassle, it’s a plus.”
🎯 Who Should Use Hims?
Assuming you meet the clinical criteria for GLP-1 therapy (BMI of 30+, or 27+ with a related health condition), Hims may be a strong fit depending on your priorities.
If cost is the main deciding factor, Hims offers one of the lowest cash prices to get started on GLP-1 medication without insurance.
Prepaid bundles make costs predictable, and there are no membership fees on top of medication costs. If you want to avoid insurance battles, this cash-pay approach is refreshingly straightforward.
If you want a program you can handle entirely online, Hims is built for that.
The intake form, provider review, and prescription all happen online, and meds ship straight to your door. You get 24/7 unlimited messaging with licensed providers at no additional cost for follow-ups, dose adjustments, or questions about side effects.
If you value privacy or are too busy for in-person visits, this level of convenience is a real advantage. It also makes the program accessible if you live somewhere weight-loss specialists or endocrinologists are hard to find.
If you want the option to choose between compounded and branded medications, Hims gives you flexibility.
Many competitors limit you to one or the other, but Hims offers both. If you’re comfortable with compounded semaglutide, you can start for as low as $199/month. If you want Wegovy, Ozempic, or tirzepatide, you can upgrade (though at a higher cost). That flexibility lets you test the waters with a cheaper compounded version before deciding if branded drugs are worth the premium. If you want to compare Hims with other top providers, we round up the best semaglutide clinics that deliver results.
Finally, if you are frustrated with insurance barriers, Hims eliminates those headaches entirely with straightforward cash pricing.
Since all plans are prepaid, you’ll know your exact monthly cost without fighting for coverage or reimbursement. While paying up front might make some people nervous, it also gives you peace of mind that your monthly cost won’t change or get derailed by insurance.
🚫 Who Is Hims Not For?
If you’re looking for close medical supervision, frequent check-ins, or detailed monitoring, Hims probably won’t go deep enough. Lab work is rarely required, check-ins are limited, and compounded medications make up much of the offering.
Patients who value FDA-approved drugs and closer medical supervision will likely feel more confident with a more clinically intensive program.
If you rely on insurance to help offset the high cost of GLP-1s, Hims isn’t built for you. The program is cash-pay only. While compounded meds are affordable, brand-name options still run hundreds to thousands per month, and Hims doesn’t provide reimbursement pathways. Patients who depend on insurance to make these drugs affordable will find Hims’ model financially unrealistic.
If you want structured coaching and community support, Hims may not provide enough. The app offers tracking tools for nutrition, movement, and sleep, plus 100+ recipes and personalized nutrition insights. But there’s no health coach, no community, and no structured follow-up to keep you engaged beyond provider messaging.
If you need ongoing motivation and accountability to stay on track, that lack of personal coaching can make weight regain more likely, and other programs like Calibrate or WeightWatchers may be a better fit.
If you need flexibility in case the program doesn’t work out, Hims may feel risky. Its prepaid, no-refund bundles mean you’re locked in whether or not the treatment meets your needs. For patients who are unsure if GLP-1s are right for them, that lack of flexibility can make Hims feel like a gamble.
If you live in a state where Hims isn’t available, you’re out of luck. Compounded semaglutide through Hims is unavailable in some states, so check availability before getting too invested in the program. If you need budget-friendly compounding options, see our review of the most affordable semaglutide providers.
How Does Hims Compare to Other Clinics?
When weighing Hims against competitors, here’s how things shake out:
| Clinic | Best for | Monthly cost | Treatment types | Lab testing | Add-ons | Insurance |
|---|---|---|---|---|---|---|
| Hers, Hims | Low cash prices with fast, app‑based care | $199–$1899 | •Compounded semaglutide; • Wegovy; • Ozempic; • Mounjaro; • Zepbound; • liraglutide | Not routinely required; $75–$100 | None | No |
| Ro Body Program | Coaching plus cash or insurance payments | $145 + medication cost | • Wegovy; • Zepbound; • compounded semaglutide | Not required; included | None | Yes |
| WeightWatchers | People who want WW’s behavior program plus medical care | $74–$84 + medication cost | • Brand-name GLP-1s; • some compounded options | Not required; included | In-person workshops ($22+) | Yes |
| Found | Coaching‑forward program that accepts insurance for brand meds | $129 for membership + medication cost (cash or copay) | • Compounded & brand-name injectables;• oral meds | Not required; not included | None | Yes |
| Mochi Health | Comprehensiveobesity care with behavioral integration | $49–$69 + meds | • Brand-name GLP-1s;• compounded semaglutide;• compounded tirzepatide | Not included | None | Yes |
- Prices above reflect each clinic’s public pages at the time of writing and exclude medication copays when routed through insurance. Programs frequently run promos and change pricing tiers, so always confirm at checkout.
- For clinics that use or emphasize compounded drugs, availability can vary by state and pharmacy, and compounded GLP-1s are not FDA approved. If you want only branded, FDA-approved meds, look at Ro or WeightWatchers.
- Even when clinics assist with insurance paperwork, GLP-1 coverage isn’t guaranteed. Many patients end up paying cash regardless, so it’s wise to prepare for that possibility when budgeting for treatment.
Real User Experience With Hims
Hims reviews run the gamut: Some users drop pounds and feel great, others battle unrelenting nausea despite solid results, and a few find the real challenge is canceling when things don’t work out.
This user was down seven pounds in 3.5 weeks with appetite finally under control—proof the medication works when your body cooperates.

Edwelly dropped 12 pounds in a month but says the nausea made life miserable. Hims does offer anti-nausea meds to eligible patients, so either he did not get them or they did not do the job.

Others had issues with customer service.

Final Verdict
Hims is best for men who want a straightforward, private way to start GLP-1 treatment without dealing with insurance or in-person visits. Its fast onboarding, transparent pricing, and all-digital experience make it appealing to anyone who values convenience and control.
But the trade-offs are clear. With limited lab testing, minimal follow-up, and a focus on compounded medications, Hims falls short on medical depth and personalized support. If you want more hands-on monitoring, ongoing coaching, or help navigating insurance for branded GLP-1s, a more comprehensive program like Ro Body Program may be a better fit.
Ready to see if Hims is right for you? Take the quick online assessment to get started today.
FAQs
Is Hims legit for weight loss?
Yes, Hims is a legitimate telehealth company for weight loss. It’s a licensed platform that connects users with real medical providers who can prescribe GLP-1 medications when clinically appropriate. The program follows standard clinical protocols for intake and prescription, though it operates entirely online and offers lighter ongoing supervision than traditional in-person weight-loss clinics.
Is Hims like Ozempic?
Hims is not like Ozempic because Hims is a telehealth platform, not a medication. However, Hims providers can prescribe semaglutide, which is the same active ingredient found in Ozempic. Depending on your eligibility and state regulations, you may receive compounded semaglutide or brand-name options like Ozempic itself. So while Hims offers access to Ozempic or similar medications, it’s the delivery method rather than the drug itself.
What if Hims weight loss doesn’t work?
If Hims weight loss doesn’t work for you, you can message your provider through the platform to discuss dose adjustments or alternative treatments. Results vary based on consistency, dosage, and lifestyle factors, so lack of progress doesn’t always mean the medication has failed.[12] Most users notice meaningful changes within a few months when they stay adherent to their plan and work with their provider on optimization.
What are the side effects of Hims weight loss meds?
The side effects of Hims weight-loss medications include nausea, fatigue, constipation, diarrhea, and digestive changes.[13] These are typical GLP-1 side effects and are usually mild to moderate in severity. If you want a quick refresher on how semaglutide works, see our overview here. Most side effects are short-term and improve as your body adjusts, especially with gradual dose increases. Serious side effects are rare but should be reported to your provider immediately for review and possible treatment adjustments.
What is in the Hims weight loss pill?
The Hims weight-loss program doesn’t use a single pill but rather a personalized medication kit that may include combinations of bupropion, metformin, naltrexone, topiramate, and vitamin B12. These medications target appetite, metabolism, and energy levels. The exact combination depends on your medical profile and your provider’s clinical judgment, ensuring the treatment plan is tailored to your specific goals and health history.
Disclaimer: This review is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing semaglutide or any GLP-1 medication.
Sources
- Ruder, K. (2025). Patients are flocking to compounded weight-loss drugs, but are they safe? JAMA, 333(8), 652–655. https://doi.org/10.1001/jama.2024.27251
- Nguyen, T. T., & Elmaleh, D. R. (2025). Clinical data mega-collection of obesity and obesity-related trials: Primary inclusion criteria from all studies and highlights of clinical efficacy analysis of GLP-1 drugs. Journal of Clinical Medicine, 14(3), 812. https://doi.org/10.3390/jcm14030812
- Schofield, M. (2021). Regulatory and legislative issues on telehealth. Nutrition in Clinical Practice, 36(4), 729–738. https://doi.org/10.1002/ncp.10740
- Tobaiqy, M. (2024). A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment. Pharmacological Reports, 76(5), 981–990. https://doi.org/10.1007/s43440-024-00629-x
- Aktiellt. (2025, June 23). Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing. https://www.swedbank-aktiellt.se/telegram/72lNdXRT
- Rao, S. S., Disraeli, P., & McGregor, T. (2004). Impaired glucose tolerance and impaired fasting glucose. American Family Physician, 69(8), 1961–1968. https://pubmed.ncbi.nlm.nih.gov/15117017/
- Chan, D. C., Watts, G. F., Ng, T. W. K., Yamashita, S., & Barrett, P. H. R. (2008). Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome. European Journal of Clinical Investigation, 38(10), 743–751. https://doi.org/10.1111/j.1365-2362.2008.02019.x
- Nevola, R., Epifani, R., Imbriani, S., Tortorella, G., Aprea, C., Galiero, R., Rinaldi, L., Marfella, R., & Sasso, F. C. (2023). GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives. International Journal of Molecular Sciences, 24(2), 1703. https://doi.org/10.3390/ijms24021703
- Sanyal, A. J., Newsome, P. N., Kliers, I., Østergaard, L. H., Long, M. T., Kjær, M. S., Cali, A. M., Bugianesi, E., Rinella, M. E., Roden, M., & Ratziu, V. (2025). Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. New England Journal of Medicine, 392(21), 2089–2099. https://doi.org/10.1056/NEJMoa2413258
- Aristizábal-Colorado, D., Corredor-Rengifo, D., Sierra-Castillo, S., López-Corredor, C., Vernaza-Trujillo, D. A., Weir-Restrepo, D., Izquierdo-Condoy, J. S., Ortiz-Prado, E., Rico-Fontalvo, J., Gómez-Mesa, J.-E., Abreu-Lomba, A, & Rivera-Martínez, W.-A. (2025). A decade of progress in type 2 diabetes and cardiovascular disease: Advances in SGLT2 inhibitors and GLP-1 receptor agonists–a comprehensive review. Frontiers in Endocrinology, 16, 1605746. https://doi.org/10.3389/fendo.2025.1605746
- Sanyal, D., & Raychaudhuri, M. (2016). Hypothyroidism and obesity: An intriguing link. Indian Journal of Endocrinology and Metabolism, 20(4), 554–557. https://doi.org/10.4103/2230-8210.183454
- Despain, D., & Hoffman, B. L. (2024). Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians. Obesity Pillars, 12, 100143. https://doi.org/10.1016/j.obpill.2024.100143
- Consoli, A., & Formoso, G. (2015). Potential side effects to GLP-1 agonists: understanding their safety and tolerability. Expert Opinion on Drug Safety, 14(2), 207–218. https://doi.org/10.1517/14740338.2015.987122
